• H. Greten
  • H. Rieger
  • H. Sinzinger
  • E. Standl
  • E. Windler


Die umfassende Problematik der Arteriosklerose kann auch nicht annähernd in einem nicht speziell der Arteriosklerose gewidmeten Lehrbuch beschrieben werden. Es können lediglich die wesentlichen Theorien zur Ursache und Entstehung der Arteriosklerose und die Rolle der in diesem Zusammenhang wichtigen (unabhängigen) vasku-lären Risikofaktoren angesprochen werden.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anitschkow N (1913) Über die Veränderung der Kaninchenaorta bei experimenteller Cholesterinsteatose. Beitr path Anat allg Pathol 56:379–384Google Scholar
  2. Austin M, Krauss RM (1986) Genetic control of low-densitylipoprotein subclasses. Lancett II: 592–594CrossRefGoogle Scholar
  3. Baer L, Radichevich J (1985) Cigarette Smoking in Hypertensive Patients. The Am J Med 78:564–569CrossRefGoogle Scholar
  4. Barret-Connor E, Ochard TJ (1985) Insulin-dependent diabetes mellitus and ischemic heart disease. Diab Care 8 Suppl 1:65–70Google Scholar
  5. Basu SK, Brown MS, Ho YK, Havel RJ, Goldstein JL (1981) Mouse macrophages synthesize and secrete a protein resembling apo E. Proc Natl Acad Sci USA 78:7545–754PubMedCrossRefGoogle Scholar
  6. Benditi EP, Benditt JM (1973) Evidence for a monoclonar origin of human atherosclerotic plaques. Proc. Nat. Acad. Sci 70:1753–1759CrossRefGoogle Scholar
  7. Blankenhorn DH, Nessim SA, Johnson RL (1987) Beneficial effects of combined colestipol-niacin therapy on coronary atheriosclerosis and coronary venous bypass grafts. JAMA 257:3233:3240PubMedCrossRefGoogle Scholar
  8. Böger RH, Bode-Böger SM, Fröhlich JC (1996) Pathogeneti-sche Bedeutung des L-Arginin-NO-Stoffwechsels bei Arteriosklerose und mögliche therapeutische Aspekte. VASA 25:305–315PubMedGoogle Scholar
  9. Borch-Johnson K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in type 1 (insulindependent) diabetes melitus. Diabetol 28:590–596Google Scholar
  10. Bots ML, Breslau PJ, Briet E et al. (1992) Cardiovaskular Determinants of Carotid Artery Disease: The Rotterdam Elderly Study. Hypertension 19:717–720PubMedCrossRefGoogle Scholar
  11. Breddin HK, Kryzwanck HJ, Althoff P, Schöffling K, Überla K (1985) PARD: Platelet aggregation as a risk factor in diabetics: Results of a prospective study. Horm Metab Res Suppl 15:63–68PubMedGoogle Scholar
  12. Breddin HK, Krzywanek HJ, Althoff P et al. (1986) Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics, International Angiology 5:181–195PubMedGoogle Scholar
  13. Breddin K (1996) Haemostaseologische Parameter als Risikofaktoren bei Gesunden (HAPARG)Google Scholar
  14. Brown MS, Kovanen PT, Goldstein JL (1981) Regulation of plasma cholesterol by lipoprotein receptors. Science 212:628–635PubMedCrossRefGoogle Scholar
  15. Brown G, Albers JJ, Fisher LD (1990) Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323:1289–1298PubMedCrossRefGoogle Scholar
  16. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl J Medicine 318:1315–1321CrossRefGoogle Scholar
  17. Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich jr PO (1984) Apoproteins B and A—I and coronary artery disease in humans. Arteriosclerosis 4:79–83PubMedCrossRefGoogle Scholar
  18. Buchwald H, Vargo RL, Matts JP and the POSCH Group (1990) Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med 323:946–955PubMedCrossRefGoogle Scholar
  19. Burr ML, Holliday RM, Fehily AM (1992) Haematological Prognostic Indices after Myocardial Infarction. Evidence form the Diet and Reinfarction Trial (DART). Eur Heart J 13:166–170PubMedGoogle Scholar
  20. Califf M, Fortin DF, Frid DJ et al. (1991) Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 17:2B–13BPubMedCrossRefGoogle Scholar
  21. Carew TE, Schwenke DC, Steinberg D (1986) Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 84:641–644Google Scholar
  22. Castelli WP, Anderson K (1986) A population at risk. Amer Journ Med 80:23–32CrossRefGoogle Scholar
  23. Castro GR, Fielding CJ (1988) Early incorporation of cellderived cholesterol into pre-ß-migrating high-density lipoprotein. Biochem 27:25–29CrossRefGoogle Scholar
  24. Chobanian A, Prescott M, Haudenschild C (1984) The Effects of Hypertension on the Arterial Wall. Exp Molecular Pathol 41:153–156CrossRefGoogle Scholar
  25. Chobanian A (1986) Hypertension. Antihypertensive Drugs and Atherogenesis — Mechanics and Clinical Implications. J Clin Hypertens 3:148–153Google Scholar
  26. Ceriello A, Guliano D, Dello Russo P et al. (1986) Metabolic control may alter antithrombin III activity but not its plasma concentration in Diabetes: a possible role for nonenzymatic glycosylation. Diab Care 9:32–35CrossRefGoogle Scholar
  27. Davies JM, Sehlton L, Hartmann CR, Eigenberg DA, Ruttinger HA (1986) Smoking-induced changes in endothelium and platelets. Br J exp Path 67:765–772Google Scholar
  28. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1–21PubMedCrossRefGoogle Scholar
  29. Deckert T, Poulsen JE, Larsen M (1978) Prognosis of diabetics with diabetes onset before the age of thirtyone. I. Survival, causes of death, and complications. Diabetol 14:363–370CrossRefGoogle Scholar
  30. Deckert T, Poulsen JW, Larsen M (1978) Prognosis of diabetics with diabetes onset before the age of thirtyone. II. Factors, influencing the prognosis. Diabetol 14:371–377CrossRefGoogle Scholar
  31. Dewey CF (1984) Effects of fluid flow on living vascular cells. J Bioch Engng 106:31–36Google Scholar
  32. Dewey CF, Davies PF, Gimbrone MA (1988) Turbulence, Disturbed Flow and Vascular Endothelium. In: Yamaguchi, Caro, Glagov, Nerem (eds) Role of Blood Flow in Atherogenesis. Springer, Berlin Heidelberg New York Tokyo, S. 201CrossRefGoogle Scholar
  33. Donald CD, Greenberg BR (1985) Cerebral Thrombosis in Smokers’ Polycythemia. Annals of Internal Medicine 102:786–792CrossRefGoogle Scholar
  34. Ducimetière P, Eschwege E, Papoz L et al. (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205–210PubMedCrossRefGoogle Scholar
  35. Duguid JB (1946) Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J Path Bact 58:207–212PubMedCrossRefGoogle Scholar
  36. Eschwege E, Richard JL, Thibult N et al. (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl 15:41–46PubMedGoogle Scholar
  37. Faggiotto A, Ross R, Harker L (1984) Studies of hypercholesterolemia in the nonhuman primate. I. changes that lead to fatty streak formation. Arteriosclerosis 4:323–340PubMedCrossRefGoogle Scholar
  38. Faggiotto A, Ross R (1984) Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4:341–356PubMedCrossRefGoogle Scholar
  39. Fernie JM, Lamb D (1986) Effect of age and smoking in intima of muscular pulmonary arteries. J clin Patho 39:1204CrossRefGoogle Scholar
  40. Fielding CJ (1984) The origin and properties of free cholesterol potential gradients in plasma, and their relation to atherogenesis. J Lipid Res 25:1624–1628PubMedGoogle Scholar
  41. Foison AR, Wukk Conian MG (1992) Fibrinogen and Cardiovascular Risk in the Atheriosclerosis Risk in Communities (ARIC) Study. In: Koenig E, Lowe E (eds) Fibrinogen: a „new“ cardiovascular Risk Factor. Vienna, Blackwell — MZV:124–129Google Scholar
  42. Fontbonne A, Eschwege E, Cambien F et al. (1989) Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow up of the Paris Prospective Study. Diabetologia 32:300–304PubMedCrossRefGoogle Scholar
  43. Fowkes FGR, Connor JM, Smith FB et al. (1992) Fibrinogen Genotype and Risk of Peripheral Atherosclerosis. Lancet 339:693–696PubMedCrossRefGoogle Scholar
  44. Franke RP, Höpken S, Schnittler HJ et al. (1987) Wirkung von Scherkräften auf humane Endothelzellen. In: Betz E (Hrsg.) Frühveränderungen bei der Atherogenese. Zuckschwerdt, S. 56Google Scholar
  45. Fredrickson DS, Levy RI, Lees S (1967) Fat transport in lipoproteins: An integrated approach to mechanisms and disorders. N Engl J Med 276:33–44Google Scholar
  46. Friedman MH, Deters OJ, Bargeron CB, Hutchins GM, Mark FF (1986) Sheardependent Thickening of the Human Arterial Intima. Atherosclerosis 60:161PubMedCrossRefGoogle Scholar
  47. Friedman MH (1988) The relationship between intimai thickening and the hemodynamic environment of the arterial wall. In: Yoshida, Caro, Nerem (Hrsg.) Role of Blood Flow in Atherogenesis. Springer, Berlin Heidelberg New York Tokyo, S. 41CrossRefGoogle Scholar
  48. Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (First part). N Engl J Med 326:242–250PubMedCrossRefGoogle Scholar
  49. Germing A, Machraoui A, Poller W, Braun BE, Barmeyer J (1996) Hypertriglyzeridämie als Risikofaktor für koronare Herzkrankheit — eine koronarangiographische Studie. Herz/Kreisl 28:282–286Google Scholar
  50. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52:1544–1568PubMedCrossRefGoogle Scholar
  51. Goldstein JL, Browns MS (1977) The low-density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 46:897–930PubMedCrossRefGoogle Scholar
  52. Goodnight SH, Wiliam SH, Connor WE, Illingworth DR (1982) Polyunsatured fatty acids, hyperlipidemia and thrombosis. Arteriosclerosis 2:87–113PubMedCrossRefGoogle Scholar
  53. Gordon T, Castelli WP, Marthana C et al. (1977) Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. Ann J Intern Med 87:393–397CrossRefGoogle Scholar
  54. Grundy SM (1986) Cholesterol and coronary heart disease. A new era. JAMA 26:2849–2858CrossRefGoogle Scholar
  55. Hamada M, Nishio I, Kusuyama Y et al. (1988) The Effect of Centrifugal Force on Glycosaminoglycans Synthesis and Cell Proliferations of Vascular Smooth Muscle Cells in Culture. In: Yamaguchi, Caro, Glagov, Nerem (eds) Role of Blood Flow in Atherogenesis. p. 217Google Scholar
  56. Hanefeld M, Fischer S, Schmechel J et al. (1991) Diabetes Intervention Study. Multiintervention trial in newly diagnosed NIDDM. Diab Care 14:308–317CrossRefGoogle Scholar
  57. Hauss WH (1968) Die unspezifische Mesenchymreaktion. Thieme StuttgartGoogle Scholar
  58. Hauss WH (1990) Die unspezifische Mesenchymreaktion. In: Hauss WH: Die Arteriosklerose, Steinkopff, 43-98Google Scholar
  59. Hauss WH (1990) Die Arteriosklerose. Steinkopff Darmstadt, S. 113Google Scholar
  60. Haverkate F (1994) Thrombosis and disabilities. In: Baya C (ed) Advances in medical biology. IOS Press: 81-103Google Scholar
  61. Henderson B (1985) Mechanisms of Atherogenesis: Endothelial Hypoxia proposed as the major initiator. Medical Hypothesis 18:297CrossRefGoogle Scholar
  62. Henerici M, Steinke W, Klötzsch C, Elz T (1991) Strömungsveränderungen in der Carotisbifurcotion — Eine Ultraschalluntersuchung beim Menschen. Vasa Suppl 32:66Google Scholar
  63. Heyden S (1986) Diabetes als kardiovaskulärer Risikofaktor — epidemiologische Übersicht. In: Gleichmann U, Sauer H, Petzoldt R, Mannebach H (Hrsg) Herz und Diabetes — Diabetes und Herz. Steinkopff, Darmstadt S. 9–24CrossRefGoogle Scholar
  64. Hillson RM, Hockaday TDR, Mann JI, Newton DJ (1984) Hyperinsulinemia is associated with development of electro-cardiographic abnormalities in diabetics. Diab Res 1:143–149Google Scholar
  65. Holm I (1990) An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 82:1916–1924CrossRefGoogle Scholar
  66. idem (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (Second part). N Engl J Med 326:310–318CrossRefGoogle Scholar
  67. Jackson RL, Gotto jr, AM (1976) Hypothesis concerning membrane structure, cholesterol, and atherosclerosis. In: Paoletti R, Gotto jr, AM (eds) Atherosclerosis reviews, No. 1. Raven Paress New York, p. 1–21Google Scholar
  68. Janka HU, Standl E, Schramm W, Mehnert H (1983) Platelet Enzyme Activities in Diabetes mellitus in Relation to Endothelial Damage. Diabetes 32 Suppl 2:47–51PubMedGoogle Scholar
  69. Janka HU (1986) Herz-Kreislauf-Krankheiten bei Diabetikern. „Schwabinger Studie“. Urban & Schwarzenberg, MünchenGoogle Scholar
  70. Janka HU, Balletshofer A, Becker A et al. (1992) Das metabolische Syndrom als potenter kardiovaskulärer Risikofaktor für vorzeitigen Tod bei Typ-II-Diabetikern. Die Schwabinger Studie II. Untersuchung nach 9 Jahren. Diab Stoffw 1:2–7Google Scholar
  71. Jarrett RJ, Viberti CG, Argyropoulos A (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diab Med 1:17–19CrossRefGoogle Scholar
  72. Johnson WJ, Mahlberg FH, Chacko GK, Phillips MC, Rothblat GH (1988) The influence of cellular and lipoprotein cholesterol contents on the flux of cholesterol between fibroblasts and high density lipoprotein. J Biol Chem 263:14099–14106PubMedGoogle Scholar
  73. Kadish JL (1979) Fibrin and Atherogenesis — a Hypothesis. Atherosclerosis 33:409PubMedCrossRefGoogle Scholar
  74. Kannel WB, Castelli WB, Gordon T (1979) Cholesterol in the prediction of atherosclerotic disease. Ann Intern Med 90:85–91PubMedCrossRefGoogle Scholar
  75. Kannel WB (1983) High-Density Lipoproteins: Epidemiologic profile and risk of coronary artery disease. Amer J Cardiol 52:9B–13BPubMedCrossRefGoogle Scholar
  76. Kannel WB, Wolf PA, Garrison RJ (eds) (1988) The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Sectioin 35. Survival Following Initial Cardiovascular Events: 30 years follow up. Bethesda; MD; US Dept of Health and Human Service, NIH, NHLBIGoogle Scholar
  77. Karino T, Goldsmith HL (1979) Adhesion of human platelets to collagen on the walls distal to a tubular expansion. Microvasc Res 17:238PubMedCrossRefGoogle Scholar
  78. Khoo JC, Miller E, McLoughlin P, Steinberg D (1988) Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis 8:348–358PubMedCrossRefGoogle Scholar
  79. Koenig W, Resch KL, Hombach V, Ernst E (1994) Fibrinogen und kardiovaskuläres Risoko. Dtsch Ärzteblatt 91:1–6Google Scholar
  80. Koenig W (1995) Recent progress in the clinical aspects of fibrinogen. The European Society of Cardiology, european Heart Journal 16 (Supplement X)Google Scholar
  81. König W (1993) The Epidemiology of Fibrinogen: Focus on Rheologicol Mechanisms. Clinical Hermorheology 13:334Google Scholar
  82. Kostner GM, Avogaro P, Cazzolato G et al. (1981) Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38:51–61PubMedCrossRefGoogle Scholar
  83. Krings W: Das Verhalten menschlicher Blutplättchen in der Rohr-und verzweigten Kanalströmung. Med Diss Aachen (1984)Google Scholar
  84. Krolewski AS, Kosinski EJ, Warram JH et al. (1987) Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Amer J Cardiol 59:750–755PubMedCrossRefGoogle Scholar
  85. Laustolia KE (1991) Atherothrombotic mechanisms in smoking. J of Int Med 230:469CrossRefGoogle Scholar
  86. Lebovitz HE (1992) Syndrome X: fact or fiction? In: Lefebvre PJ, Standl E (eds) New aspects in diabetes. De Gruyter, Berlin New York S. 23–33Google Scholar
  87. Lefebvre XP (1991) Effect of Vessel Geometry on the Flow Field. In: Lanzer P, Yoganathan AP (eds) Vascular imaging by color doppler and magnetic resonance S. 58Google Scholar
  88. Lesmes GR (1992) The effects of cigarette smoking: a global perspective. The American Journal of Medicine 93: suppl. 1AGoogle Scholar
  89. Liepsch D (1991) Wechselwirkung von geometrisch hämorheologischen Parametern bei der Entstehung von Sekundarströmung in dehnbaren Gefäßmodellen, VASA Suppl 32:-18PubMedGoogle Scholar
  90. Linzbach AJ (1974) Die Bedeutung physikalischer Faktoren in der Gefäßwand für die formale Pathogenese der Arteriosklerose. In: Heberer G, Rau G, Schoop W (Hrsg.) Angiologie. Thieme, Stuttgart S. 40Google Scholar
  91. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson JC, Witztum JL (1988) Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-de-rived macrophages. Diabetes 37:550–557PubMedCrossRefGoogle Scholar
  92. Lowe GDO, Fowkes FGR, Dawes J et al. (1993) Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 87:1915–1920PubMedCrossRefGoogle Scholar
  93. Lüscher TF, Oemar BS, Yang Z, Noll G (1996) Molekulare und zelluläre Mechanismen der Arteriosklerose und Restenose. Z Kardiol 85:495–508PubMedGoogle Scholar
  94. Lupatelli G, Siepi D, Pasqualini L, Ciuffetti G, Sinzinger H, Mannarino E (1994) Lipoprotein (a) in peripheral arterial occlusive disease. VASA 23:321–324Google Scholar
  95. Mahley RW (1985) Atherogenic lipoproteins and coronary artery disease: Concepts derived from recent advances in cellular and molecular biology. Circulation 72:943–948PubMedCrossRefGoogle Scholar
  96. Mann S, James G, Wang S, Pickering G (1991) Elavation of ambulatory systolic blood pressure in hypertensive smokers. J am Med Assoc 265:2226CrossRefGoogle Scholar
  97. Marasini B, Biondi L, Barbesti S, Zatta G, Agostoni A (1986) Cigarette Smoking and Platelet Function. Thrombosis Research 44:85PubMedCrossRefGoogle Scholar
  98. Marre R, Essig A (1997) Chlamydia pneumonial und Atherosklerose. Dtsch med Wschr 122:1092–1095PubMedGoogle Scholar
  99. Martin JF, Bath PMW, Burr ML (1991) Influence of Platelet Size on Outcome After Myocardial Infarction. Lancet 338:1409–1411PubMedCrossRefGoogle Scholar
  100. Mayfield RK, Halushka PV, Wohltmann HJ et al. (1985) Platelet function during continous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes 34:1127–1133PubMedCrossRefGoogle Scholar
  101. McGill HC (1988) The cardiovascular pathology of smoking. Am Heart J 115:250PubMedCrossRefGoogle Scholar
  102. Mey J, Grunwald J, Schöper W, Schulte H, Hauss WH (1984) About the effect of risk factors on the structure and the proliferation of arterial wall cells. Exp Path: 163Google Scholar
  103. Meyer WW (1974) Einführung in die Pathomorphologie der Arterien. In: Heberer G, Rau G, Schoop W (Hrsg) Angiologie. Thieme, Stuttgart. S. 40Google Scholar
  104. Miesenböck G, Patsch JR (1990) Relationship of triglyceride and high-density lipoprotein metabolism. Atherosclerosis Reviews 21:119–127Google Scholar
  105. Mizuno K, Yaginuma K (1982) Acute Effect of Cigarette Smoking on Serum Agiotensin — converting Enzym Acitivity in Normal Man. Tohoku J exp Med 137:113PubMedCrossRefGoogle Scholar
  106. Modesti P, Fortini A, Abbate R, Gensini G (1985) Cigarette Smoking Does not affect PGJ2. Platelet Receptors. Thrombosis Research 37:343PubMedCrossRefGoogle Scholar
  107. Mogensen CE (1984) Diabetes and kidney function. A comparison between type 1 and type 2 diabetes. Medicographia 6:28–32Google Scholar
  108. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356–360PubMedCrossRefGoogle Scholar
  109. Moneada S, Hermann AG, Higgs EA, Vane JR (1977) Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall: an explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res 11:323–344CrossRefGoogle Scholar
  110. Moore J (1986) Smoking, Drinking an polycythaemia. Br Med J 292:1617CrossRefGoogle Scholar
  111. Morel DW, DiCorleto PE, Chisolm GM (1984) Endothelial and smooth muscle cells alter low density lipoprotein in vito by free radical oxidation. Arteriosclerosis 4:357–364PubMedCrossRefGoogle Scholar
  112. Naumann A, Schmid-Schönbein H (1983) A Fluid-Dynamicist’s and a Physiologist’s Look at Arterial Flow and Arteriosklerosis. In: Fluid Dynamics as a Localizing Factor for Atherosclerosis. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  113. Nava E, Lüscher F (1995) Endothelium and hypertension. In: Vane H, Born G, Welzel D (eds) The endothelial cell in health and disease. Schattauer Verlag, pp 37-50Google Scholar
  114. Opitz K (1992) Inhaltsstoffe des Zigarettenrauches und ihre gesundheitliche Bedeutung. In: Jork K, v. Troschke J, Rieger H (Hrsg) Gesundheitsberatung zur Tabakentwöhnung — Ein Handbuch für Ärzte. Gustav Fischer, S. 29Google Scholar
  115. Oram JF, Johnson CJ, Brown TA (1987) Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages — Evidence for reversible binding at the cell surface without internalization. J Biol Chem 262:2405–2410PubMedGoogle Scholar
  116. Ornish D, Brown SE, Scherwitz LW, Billings JH et al. (1990) Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet i 336:129–133CrossRefGoogle Scholar
  117. Palinski W, Rosenfeld ME, Ylä-Herttuala S et al. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86:1372–1376PubMedCrossRefGoogle Scholar
  118. Panzram G (1987) Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 20:123–131CrossRefGoogle Scholar
  119. Panzram G, Zabel-Langhennig R (1989) Epidemiologic und Prognose des Diabetes mellitus. In: Bibergeil H (Hrsg) Diabetes mellitus. Fischer, Jena, S. 145-165Google Scholar
  120. Phillipp Th (1986) Sympathisches Nervensystem bei essentieller Hypertonie: Aktivität und Reaktivität. In: Rosenthal J (Hrsg) Arterielle Hypertonie. Springer, Berlin Heidelberg New York Tokyo, S. 50Google Scholar
  121. Philips NR, Havel RJ, Kane JP (1981) Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine. Arteriosclerosis 5:153–161Google Scholar
  122. Pitas RE, Innerarity TL, Mahley RW (1982) Identification of foam cells with receptors for ß-very low density lipoproteins and modified low density lipoproteins in expiants of atherosclerotic rabbit aortas. Arteriosclerosis 3:2–12Google Scholar
  123. Pittilo RM, Bull HA, Gulati S et al. (1990) Nicotine and cigarette smoking effects on the ultrastructure of aortic endothelium. Int J exp Patho 71:573Google Scholar
  124. Pyörälä K (1985) Diabetes and coronary heart disease. Acta Endocrinol 110 Suppl 272:11–19Google Scholar
  125. Rängemark C, Ciabattoni G, Wenmalm Ä (1993) Excretion of Thromboxane Metabolites in Healthy Woman After Cessation of Smoking. Arteriosclerosis and Thrombosis 13:777PubMedCrossRefGoogle Scholar
  126. Reidy MA, Bowyer DE (1977) — 186 Atherosclerosis 26:181CrossRefGoogle Scholar
  127. Rieger H, Biester C, Buchhaas U, Schröder C (1980) Vorläufige Ergebnisse einer Feldstudie über das Verhalten rheologischer Parameter bei Patienten mit arterieller Verschlußkrankheit und klinisch gesunden Kontrollpersonen unter Berücksichtigung verschieden kombinierter Risikofaktoren. In: Müller-Wiefei H (Hrsg) Mikrozirkulation und Blutrheologie. Witzstrock, Baden-Baden, S. 54–59Google Scholar
  128. Rietbrock N, Kunkel S, Wörner W, Eyer P (1991) Oxygen-dissociation Kinetics in the blood of smokers and non smokers. Naunyn-Schmiedebergs Archives of Pharmacology 344:512–517Google Scholar
  129. Rinninger F, Pittman RC (1988) Regulation of the selective uptake of high density lipoprotein-associated cholesteryl esters by human fibroblasts and Hep G2 hepatoma cells. J Lipid Res 29:1179–1194PubMedGoogle Scholar
  130. Rokitansky C v (1852) Über einige der wichtigsten Krankheiten der Arterien. K. u. K. Hof-und Staatsdruckerei, WienGoogle Scholar
  131. Romanski B, Zbikowska M, Kokol J, Siukiewicz W (1984) The immunologic response to tobacco antigens in smokers. Allergol et Immunopathol. 12 4:321Google Scholar
  132. Ross R (1976) The pathogenesis of atherosclerosis. N Engl J Med 295:369–377, 420-425PubMedCrossRefGoogle Scholar
  133. Ross R (1986) Medical progress. The pathogenesis of atherosclerosis — an update. New Engl J Med 314:488–500PubMedCrossRefGoogle Scholar
  134. Ross T, Runyon A, Davis HR (1987) Protection from atherosclerotic lesions formation by reduction of artery wall motion. J vasc surg 5:59Google Scholar
  135. Sakata N, Fukushima T, Takebayashi S, Homma T (1988) Distribution and Endothelial Morphology of Atherosclerotic Lesions at Bifurcations and Curves of Human Cerebral Arteries. In: Yoshida, Caro, Nerem (eds) Role of blood flow in Atherogenesis. Springer, Berlin Heidelberg New York Tokyo, S. 212Google Scholar
  136. Schaefer EJ (1984) Clinical, biochemical and genetic features in familial disorders of high density lipoprotein deficiency. Arteriosclerosis 4:303–322PubMedCrossRefGoogle Scholar
  137. Schmitt G, Knoche H, Junge-Hülsing G, Koch R, Hauss WH (1970) Über die Reduplikation von Aortenwandzellen bei arterieller Hypertonie. Zschr Kreislaufforsch 59:481PubMedGoogle Scholar
  138. Schoop W (1984) Spätergebnisse bei konservativer Therapie der arteriellen Verschlußkrankheit. Internist 25:429PubMedGoogle Scholar
  139. Schulte H, Heinrich J, Assmann G (1992) Fibrinogen und koronare Herzkrankheiten, Ergebnisse der PROCAM Studie. In: Heinle H, Schulte H, Schäfer HE (Hrsg): Arteriosklerotische Gefäßerkrankungen. Edition dino, S. 37Google Scholar
  140. Seidel D (1993) Risikofaktoren der Arteriosklerose. Unterschiedliche Profile — unterschiedliche Mechanismen? Z Kardiolog 82 Suppl 1 S. 21Google Scholar
  141. Seiffge D (1991) Thrombotische Reaktionen an Gefäßwandverzweigungen. VASA Suppl 32:54PubMedGoogle Scholar
  142. Simpson HS, Williamson CM, Pringle S et al. (1991) Hypolipidemic drugs and chylomicron metabolism. In: Windler E, Greten H (Hrsg) Intestinal lipid and lipoprotein metabolism. W. Zuckschwerdt, München San Francisco, S. 194–201Google Scholar
  143. Sinzinger H (1983) Die Rolle der Prostaglandine bei der Entstehung von Gefäßveränderungen bei Diabetikern. Haemostaseologie 3:97–101Google Scholar
  144. Sinzinger H, Virgolini I (1990) Nuclear medicine and atherosclerosis. Europ J Nucl Med 17:160–178CrossRefGoogle Scholar
  145. Stamler J (1983) Nutrition-related risk factors for the atherosclerotic diseases — Present status. Prog biochem Pharmacol 192:45–308Google Scholar
  146. Stamler J (1987) Epidemiology, established major risk factors, and the primary prevention of coronary heart disease. In: Parmely W, Chatterjee K (eds) Cardiology. Lippincott, Philadelphia, p 1–41Google Scholar
  147. Standl E, Janka HU (1985) High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type II diabetics. Horm Metabol Res Suppl 15:46–51Google Scholar
  148. Standl E, Stiegler H, Janka HU, Mehnert H (1988) Risk profile of macrovascular disease in diabetes mellitus. Diab Metab 14:505–511Google Scholar
  149. Standl E, Janka HU (1989) Diabetes mellitus und Gefäßkrankheiten — Gesamtschau. In: Bibergeil H (Hrsg) Diabetes mellitus (3. Aufl.) Fischer, Jena S. 437–468CrossRefGoogle Scholar
  150. Standl E, Janka HU, Stiegler H, Mehnert H (1992) Hyperinsulinemia and macrovascular complications in NIDDM. In: Lefebvre P, Standl E (eds) New Aspects in Diabetes. Treatment Strategies with Alpha-Glucosidase Inhibitors. De Gruyter, Berlin, S. 87–95Google Scholar
  151. Standl E, Stiegler H (1993) Microalbuminuria in a random cohort of recently diagnosed Type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich Area. Diabetologia 36 in pressGoogle Scholar
  152. Stary HC (1989) Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 9 (suppl I): 19–23Google Scholar
  153. Stary HC, Blankenhorn DH, Chandler AB, Glagov S et al. (1992) A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the committee on vascular lesions of the council on arteriosclerosis, AHA. Circulation 85:391–405PubMedCrossRefGoogle Scholar
  154. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: Modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924PubMedCrossRefGoogle Scholar
  155. Steinberg D, Witztum JL (1990) Lipoproteins and atherogenesis — Current concepts. JAMA 264:3047–3052PubMedCrossRefGoogle Scholar
  156. Stiegler, H, Standl E, Schulz K et al. (1992) Morbidity, mortality, and albuminuria in type 2 diabetic patients: a 3-year prospective study of a random cohort in general practice. Diab Med 9:646–653CrossRefGoogle Scholar
  157. Stiegler H, Standl E, Schulz K et al (1993) Häufigkeit, Risikoprofil und Letalitätsrate einer Stichprobe von Typ-II-Diabetikern mit Mikroalbuminurie in der ärztlichen Praxis. Eine prospektive 5-Jahres-Verlaufsuntersuchung. Diab Stoffw 2:62–67Google Scholar
  158. Stille W (1997) Arteriosklerose — eine Infektion durch Chlamydia pneumoniae. Dtsch med Wschr 122:1086–1091PubMedGoogle Scholar
  159. Stout RW (1990) Insulin and atheroma — 20-year perspective. Diabetes Care 13:631–654PubMedCrossRefGoogle Scholar
  160. Thoma R (1883) Über die Abhängigkeit der Bindegewebsneu-bildung in der Arterienintima von den mechanischen Bedingungen des Blutkreislaufes: Erste Mitteilung. Virchows Arch Pathol Anat Physiol 93:443–505CrossRefGoogle Scholar
  161. Thomas G, Skrinska V, Lucas FV (1985) Platelet glutathione and thromboxane synthesis in diabetes. Diabetes 34:951–954PubMedCrossRefGoogle Scholar
  162. Thomas PS, Schreck RE, Lazarus S (1992) Tobacco smoke releases preformed mediators from canine mast cells and modulates prostaglandin production. Am J of Physiol 263:67Google Scholar
  163. Thompson SG, Kienast J, Pyke StDM, Haverkate F, van de Loo JCW: For the european concerted action on thrombosis and disabilities angina pectoris study groupe (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. The New England Journal of Medicine 332, 635–641Google Scholar
  164. Tobelem G, Pellerin A, Areen JC, Caen J: On behalf of the Rivage Groupe Study (1994) Does the predictive power of plasmafibrinogen depend on the extent of atherothrom-botic disease? Blood Coag Fibrinol 5: (Suppl 2) Abstr 0-30Google Scholar
  165. Vanhoutte PM, Eber B (1991) Endothelium-derived relaxing and contracting factors. Wien Klin Wochenschr 103:405–411PubMedGoogle Scholar
  166. Viberti GJ, Jarrett RJ, Mahmud U et al. (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet 1:1430–1432PubMedCrossRefGoogle Scholar
  167. Virchow RV (1856) Phlogose und Thrombose im Gefäßsystem. Gesammelte Abhandlungen zur wissenschaftlichen Medizin. Hirsch, BerlinGoogle Scholar
  168. Waite CL (1980) Carboxyhaemoglobin levels in workers in Leicestershire garages. Br J Industrial Med 37:197Google Scholar
  169. Welborn T, Wearne K (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diab Care 2:154–160CrossRefGoogle Scholar
  170. West KM, Ahuja MMS, Bennett PH, Czyczyk A et al (1983) The role of circulating glucose and triglyceride concentrations and their interactions with other „risk factors“ as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diab Care 6:361–369CrossRefGoogle Scholar
  171. West RJ, Rüssel MAH, Marvis MJ, Kadam B (1984) Urinary adrenaline concentrations during 10 days of smoking abstinence. Psychopharmacology 84:141PubMedCrossRefGoogle Scholar
  172. Wilhelmsen L, Wedel H, Tibbling G (1973) Multivariate analysis of risk factors for coronary heart disease. Circulation 48:950–958PubMedCrossRefGoogle Scholar
  173. Windaus A (1910) Über den Gehalt normaler und atheromatöser Aorten an Cholesterin und Cholesterinestern. Hoppe Seylers Z Physiol Chem 67:174–176CrossRefGoogle Scholar
  174. Wiseman S, Kenchington B, Dain R et al. (1989) Influence of smoking and Plasma Factors on Patency of Femopopliteal Vein Grafts. Br Med J 299:643–646CrossRefGoogle Scholar
  175. Witztum J (1994) The oxidation hypothesis of atherosklerosis. Lancet 344:1216–1221CrossRefGoogle Scholar
  176. Woolf N (1982) Pathology of Atherosclerosis, Butterworth Scientific, London, p. 25Google Scholar
  177. Wurzinger L (1986) Die Bedeutung der fluiddynamisch induzierten viskosen Metamorphose der Blutplättchen für die Abscheidungsthrombose. Habil Schrift, AachenGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • H. Greten
  • H. Rieger
  • H. Sinzinger
  • E. Standl
  • E. Windler

There are no affiliations available

Personalised recommendations